Cognition Therapeutics Announces Positive Results in Phase 2 Study of CT1812 in Dementia with Lewy Bodies

- Improvements Across Measures of Behavior, Function, Cognition and Movement -

- Expediting Plans to Advance CT1812 into Late-Stage Trials -

Read more at globenewswire.com